Annals of internal medicine
-
Liu J, Li L, Li S, et al. Sodium-glucose co-transporter-2 inhibitors and the risk of diabetic ketoacidosis in patients with type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials. Diabetes Obes Metab. 2020;22:1619-27. 32364674.
-
The clinical utility of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) antibodies remains undefined. ⋯ Clinical Immunology Laboratory, Department of Pathology, Johns Hopkins Hospital.
-
Influenza may contribute to the burden of acute cardiovascular events during annual influenza epidemics. ⋯ Centers for Disease Control and Prevention.
-
Comment
Treatment effect of aspirin for primary prevention does not differ according to baseline ASCVD risk.
Nudy M, Cooper J, Ghahramani M, et al. Aspirin for primary atherosclerotic cardiovascular disease prevention as baseline risk increases: a meta-regression analysis. Am J Med. 2020;133:1056-64. 32445718.